Literature DB >> 7983622

0-7-21 radiation therapy for the treatment of canine oral melanoma.

K E Bateman1, P A Catton, P W Pennock, S A Kruth.   

Abstract

Eighteen dogs with malignant melanoma of the oral cavity were treated with high-dose per fraction (0-7-21) radiation therapy. Eight hundred cGy was administered on days 0, 7, and 21 for a total dose of 2,400 cGy in 3 weeks. Of 17 dogs evaluated, 9 (53%) had a complete remission and 5 (30%) achieved a partial remission with an overall response rate of 83%. Local failure occurred in 2 of the 9 dogs where a complete response was initially observed. One dog died of intercurrent disease, and one died of metastatic disease without evidence of local recurrence. Five dogs are alive and free of disease 9 to nineteen months from the initiation of therapy. The 0-7-21 protocol was well-tolerated, and acute radiation reactions were low-grade and limited to the skin. The results of this study demonstrate that oral melanomas in dogs are responsive to radiation. 0-7-21 radiation therapy offers a viable alternative to radical excision, especially when tumor volume or location would require cosmetically or functionally debilitating surgery.

Entities:  

Mesh:

Year:  1994        PMID: 7983622     DOI: 10.1111/j.1939-1676.1994.tb03231.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

1.  Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.

Authors:  Jack C F Liao; Polly Gregor; Jedd D Wolchok; Francesca Orlandi; Diane Craft; Carrie Leung; Alan N Houghton; Philip J Bergman
Journal:  Cancer Immun       Date:  2006-04-21

2.  Bilateral phalangeal fillet technique for metacarpal pad reconstruction in a dog.

Authors:  Tania Shaw; Fleur James; Lucas Beierer; Giselle Hosgood
Journal:  Can Vet J       Date:  2014-10       Impact factor: 1.008

3.  6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.

Authors:  Esther Chon; Brandi Flanagan; Lucas Campos de Sá Rodrigues; Caroline Piskun; Timothy J Stein
Journal:  Vet J       Date:  2014-07-31       Impact factor: 2.688

4.  Clinical systemic lupeol administration for canine oral malignant melanoma.

Authors:  Inoru Yokoe; Kazuo Azuma; Keishi Hata; Toshiyuki Mukaiyama; Takahiro Goto; Takeshi Tsuka; Tomohiro Imagawa; Norihiko Itoh; Yusuke Murahata; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  Mol Clin Oncol       Date:  2014-10-30

5.  Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Authors:  Carla Rohrer Bley; Dagmar Laluhova; Malgorzata Roos; Barbara Kaser-Hotz; Stefanie Ohlerth
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

6.  Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence.

Authors:  Elizabeth A Wood; Zhanping Lu; Shuai Jia; Anna L F V Assumpção; Matthew A Van Hesteren; Mike K Huelsmeyer; David M Vail; Xuan Pan
Journal:  Vet Comp Oncol       Date:  2019-10-30       Impact factor: 2.613

Review 7.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

8.  Potential for BioXmark liquid fiducial marker to improve identification of superficial component of canine oral tumors for computer-based radiation therapy planning.

Authors:  Benoit Clerc-Renaud; Mary-Keara Boss; Lynn R Griffin; Susan M LaRue; Del Leary
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

9.  Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Authors:  L A Piras; F Riccardo; S Iussich; L Maniscalco; F Gattino; M Martano; E Morello; S Lorda Mayayo; V Rolih; F Garavaglia; R De Maria; E Lardone; F Collivignarelli; D Mignacca; D Giacobino; S Ferrone; F Cavallo; P Buracco
Journal:  Vet Comp Oncol       Date:  2016-05-04       Impact factor: 2.613

10.  Radiation up-regulates the expression of VEGF in a canine oral melanoma cell line.

Authors:  Irene Flickinger; Barbara C Rütgen; Wilhelm Gerner; Ivana Calice; Alexander Tichy; Armin Saalmüller; Miriam Kleiter
Journal:  J Vet Sci       Date:  2013-06-21       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.